Insights and Interventions

Despoina Gyriki,Christos Nikolaidis,Elisavet Stavropoulou,Ioanna Bezirtzoglou,Christina Tsigalou,Stergios Vradelis,Eugenia Bezirtzoglou
DOI: https://doi.org/10.3390/jpm14050507
IF: 3.5083
2024-05-12
Journal of Personalized Medicine
Abstract:Inflammatory Bowel Disease (IBD), encompassing Crohn's disease (CD) and ulcerative colitis (UC), is a chronic and relapsing inflammatory condition of the intestine that significantly impairs quality of life and imposes a heavy burden on healthcare systems globally. While the exact etiology of IBD is unclear, it is influenced by genetic, environmental, immunological, and microbial factors. Recent advances highlight the gut microbiome's pivotal role in IBD pathogenesis. The microbial dysbiosis characteristic of IBD, marked by a decline in beneficial bacteria and an increase in pathogenic microbes, suggests a profound connection between microbial imbalance and disease mechanisms. This review explores diagnostic approaches to IBD that integrate clinical assessment with advanced microbiological analyses, highlighting the potential of microbiome profiling as a non-invasive diagnostic tool. In addition, it evaluates conventional and emerging treatments and discusses microbiome-targeted intervention prospects, such as probiotics, symbiotics, and faecal microbiota transplantation. The necessity for future research to establish their efficacy and safety is emphasised.
medicine, general & internal,health care sciences & services
What problem does this paper attempt to address?